107 related articles for article (PubMed ID: 28792699)
21. Prognostic value of circulating microRNA-21 for breast cancer: a systematic review and meta-analysis.
Jinling W; Sijing S; Jie Z; Guinian W
Artif Cells Nanomed Biotechnol; 2017 Sep; 45(6):1-6. PubMed ID: 27684463
[TBL] [Abstract][Full Text] [Related]
22. A meta-analysis of microRNA-17 as a potential biomarker in diagnosis of colorectal cancer.
Liu T; Yin L; Yan G; Li C; Wang L
Cell Mol Biol (Noisy-le-grand); 2018 May; 64(6):86-93. PubMed ID: 29808806
[TBL] [Abstract][Full Text] [Related]
23. The diagnostic role of microRNA-34a in breast cancer: a systematic review and meta-analysis.
Imani S; Zhang X; Hosseinifard H; Fu S; Fu J
Oncotarget; 2017 Apr; 8(14):23177-23187. PubMed ID: 28423566
[TBL] [Abstract][Full Text] [Related]
24. Serum MicroRNA-125b as a Potential Biomarker for Glioma Diagnosis.
Wei X; Chen D; Lv T; Li G; Qu S
Mol Neurobiol; 2016 Jan; 53(1):163-170. PubMed ID: 25416859
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-21 as a potential diagnostic biomarker for breast cancer patients: a pooled analysis of individual studies.
Gao Y; Cai Q; Huang Y; Li S; Yang H; Sun L; Chen K; Wang Y
Oncotarget; 2016 Jun; 7(23):34498-506. PubMed ID: 27153564
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of microRNA-145 in patients with various cancers: a meta-analysis.
Dai SL; Zhou J; Pan C; Huang G; Shi ZL; Yang SY; Yang KX
Cancer Biomark; 2015; 15(4):507-13. PubMed ID: 25792469
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA biomarkers in whole blood for detection of pancreatic cancer.
Schultz NA; Dehlendorff C; Jensen BV; Bjerregaard JK; Nielsen KR; Bojesen SE; Calatayud D; Nielsen SE; Yilmaz M; Holländer NH; Andersen KK; Johansen JS
JAMA; 2014 Jan 22-29; 311(4):392-404. PubMed ID: 24449318
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic value of circulating microRNAs for nasopharyngeal cancer: a systematic review and meta-analysis.
Wang Z; Chen W; Zhang Y; Xu L; Wang Q
J Cancer Res Ther; 2014 Nov; 10 Suppl():C173-8. PubMed ID: 25450278
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Role of MicroRNA-126 for Survival in Malignant Tumors: A Systematic Review and Meta-Analysis.
Bu J; Li H; Li XY; Liu LH; Sun W; Xiao T
Dis Markers; 2015; 2015():739469. PubMed ID: 26351404
[TBL] [Abstract][Full Text] [Related]
30. Identification of microRNAs as novel biomarkers for glioma detection: a meta-analysis based on 11 articles.
Qu S; Guan J; Liu Y
J Neurol Sci; 2015 Jan; 348(1-2):181-7. PubMed ID: 25510379
[TBL] [Abstract][Full Text] [Related]
31. Urinary and Blood MicroRNA-126 and -770 are Potential Noninvasive Biomarker Candidates for Diabetic Nephropathy: a Meta-Analysis.
Park S; Moon S; Lee K; Park IB; Lee DH; Nam S
Cell Physiol Biochem; 2018; 46(4):1331-1340. PubMed ID: 29689545
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic value of circulating microRNAs for lung cancer: a meta-analysis.
Shen Y; Wang T; Yang T; Hu Q; Wan C; Chen L; Wen F
Genet Test Mol Biomarkers; 2013 May; 17(5):359-66. PubMed ID: 23387316
[TBL] [Abstract][Full Text] [Related]
33. Potential Role of Circulating microRNA-21 for Hepatocellular Carcinoma Diagnosis: A Meta-Analysis.
Liao Q; Han P; Huang Y; Wu Z; Chen Q; Li S; Ye J; Wu X
PLoS One; 2015; 10(6):e0130677. PubMed ID: 26114756
[TBL] [Abstract][Full Text] [Related]
34. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis.
Zhang L; Cao D; Tang L; Sun C; Hu Y
Int J Lab Hematol; 2016 Dec; 38(6):589-599. PubMed ID: 27870469
[TBL] [Abstract][Full Text] [Related]
35. Plasma microRNA might as a potential biomarker for hepatocellular carcinoma and chronic liver disease screening.
Jiang L; Li X; Cheng Q; Zhang BH
Tumour Biol; 2015 Sep; 36(9):7167-74. PubMed ID: 25894380
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic value of microRNAs as biomarkers for cholangiocarcinoma.
Liang Z; Liu X; Zhang Q; Wang C; Zhao Y
Dig Liver Dis; 2016 Oct; 48(10):1227-32. PubMed ID: 27476468
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the diagnostic value of various microRNAs in blood for colorectal cancer: a systematic review and network meta-analysis.
Xu J; Pan L; Wu D; Yao L; Jiang W; Min J; Xu S; Deng Z
BMC Cancer; 2024 Jun; 24(1):770. PubMed ID: 38926893
[TBL] [Abstract][Full Text] [Related]
38. Circulating miR-31 as an effective biomarker for detection and prognosis of human cancer: a meta-analysis.
Ma Y; Chen Y; Lin J; Liu Y; Luo K; Cao Y; Wang T; Jin H; Su Z; Wu H; Chen X; Cheng J
Oncotarget; 2017 Apr; 8(17):28660-28671. PubMed ID: 28404921
[TBL] [Abstract][Full Text] [Related]
39. Predictive power of circulating miRNAs in detecting colorectal cancer.
Zeng W; Tu Y; Zhu Y; Wang Z; Li C; Lao L; Wu G
Tumour Biol; 2015 Apr; 36(4):2559-67. PubMed ID: 25527153
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of urine fibronectin as a non-invasive diagnostic biomarker in bladder cancer patients: a systematic review and meta-analysis.
Dong F; Shen Y; Xu T; Wang X; Gao F; Zhong S; Chen S; Shen Z
World J Surg Oncol; 2018 Mar; 16(1):61. PubMed ID: 29562940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
